The biological relevance of laminin 5gamma2 expression at the invading edge of colonic carcinomas.
Previous studies have shown the presence of dilated neoplastic glands with cellular gaps called glandular pores (GPs) and laminin 5gamma2 expression at the invading edge of colonic carcinomas. We now extended our studies to explore a possible association between GP formation and laminin 5gamma2 expression at the invading edge of colonic carcinomas. Immunostain was performed on sections of five consecutive neoplastic glands with and without GPs from 86 colonic adenocarcinomas to assess the expression of laminin 5gamma2. Neoplastic glands with GPs were observed in 85% (73/86) of the tumors. Laminin 5gamma2 was expressed in 92% (335/365) of the neoplastic glands with GPs but only in 17% (63/365) of the neoplastic glands without GPs (p<0.05). Laminin 5gamma2 was overexpressed in the cells at the free ends of the pores in 88% of the neoplastic glands with GPs, but only in 14% of those without pores (p<0.05). Hence, at the growing edge of colonic carcinomas, laminin 5gamma2 was frequently expressed in neoplastic glands having GPs. Remarkably, the tumor cells at the free ends of the GPs overexpressed laminin 5gamma2, indicating increased production of this adhesion-migration macromolecule. The results suggest a close interaction between this adhesion-migration macromolecule, PG formation and the local progression of colonic carcinomas.
Lenander
Clase
C
Department of Clinical Science, Intervention and Technology, Karolinska Institute and Centre of Gastrointestinal Disease, Ersta Hospital, and Pathology, Karolinska Institute and University Hospital Stockholm, Sweden.
Rubio
Carlos A
CA
Cancer Sci. 2006 Feb;97(2):91-8
16441418
Lancet. 1992 Dec 5;340(8832):1369-73
1360088
Int J Mol Med. 2002 Aug;10(2):205-10
12119560
Virchows Arch. 2007 Mar;450(3):273-8
17235566
Anal Cell Pathol. 2001;22(4):201-9
11564896
Anticancer Res. 2003 Jul-Aug;23(4):3555-60
12926106
Semin Cancer Biol. 2002 Jun;12(3):197-207
12083850
Dis Colon Rectum. 1993 Jul;36(7):627-35
8348847
Dis Colon Rectum. 2002 Nov;45(11):1520-7
12432301
Biochem J. 2003 Apr 1;371(Pt 1):211-21
12519076
Cancer Res. 1995 Nov 1;55(21):5049-53
7585550
Histopathology. 2005 Jul;47(1):25-31
15982320
Anticancer Res. 2003 Jan-Feb;23(1A):347-50
12680235
Anticancer Res. 2003 Sep-Oct;23(5b):4313-8
14666644
J Cell Biol. 2000 Feb 7;148(3):615-24
10662785
Cancer Res. 1995 Sep 15;55(18):4132-9
7664291
Science. 1997 Jul 11;277(5323):225-8
9211848
Cancer. 1994 Apr 15;73(8):2076-82
8156513
Nat Rev Cancer. 2003 May;3(5):362-74
12724734
Dis Colon Rectum. 2005 Dec;48(12):2197-208
16400510
Adv Cancer Res. 2000;78:31-101
10547668
In Vivo. 2003 Jan-Feb;17(1):97-100
12655799
Mol Pathol. 2003 Dec;56(6):342-6
14645697
J Cell Sci. 1998 Jul 30;111 ( Pt 14):1993-2004
9645947
Anticancer Res. 2004 May-Jun;24(3a):1765-8
15274353
Clin Exp Metastasis. 2000;18(6):439-43
11592300
Int J Cancer. 2001 Sep 1;93(5):644-52
11477573
Anticancer Res. 2003 May-Jun;23(3C):3015-8
12926155
Transl Res. 2007 Feb;149(2):96-102
17240321
Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):175-82
10981868
Dis Colon Rectum. 1997 Jan;40(1):51-9
9102262
Int J Clin Exp Pathol. 2008 Jan 01;1(2):98-104
18784803